SCHEMBL23723955

SCHEMBL23723955

O=C(O)Cc1ncoc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AGBL2 Q5U5Z8 2/20 0.45
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
GABRR1 P24046 1/20 0.36
NOTUM Q6P988 1/20 0.33
RXRA P19793 2/20 0.33
RXRB P28702 2/20 0.33
RXRG P48443 2/20 0.33
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.30
MAPT P10636 1/20 0.30
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30
PSENEN Q9NZ42 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17839864 0.78 SMN1; SMN2 (0.41) ALDH1A1KDM4ESMN1; SMN2MAPT
SCHEMBL23859064 0.77 CYP1A2 (0.30)
SCHEMBL25371860 0.73
SCHEMBL6712056 0.72 GABRR1 (0.47) AGBL2MEN1ALDH1A1GAAKMT2A
SCHEMBL17859552 0.72 ADORA2A (0.36) ALDH1A1NOTUMKDM4ESMN1; SMN2MAPT
SCHEMBL11130030 0.67 THRB (0.39) AGBL2MEN1ALDH1A1GAAKMT2A
SCHEMBL17859504 0.67 FBP1 (0.44) AGBL2ALDH1A1GABRR1NOTUMKDM4E
Bromide SCHEMBL25373420 0.66 SNCA (0.34)
SCHEMBL20031269 0.65 GAA (0.41) AGBL2GAAGABRR1NOTUMKDM4E
SCHEMBL19309585 0.63 GSK3B (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021156439-A1 TRIAZOLE COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2021-08-12 WO disclosed
WO-2021156439-A1 TRIAZOLE COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2021-08-12 WO disclosed